1. Home
  2. ARWR vs VLY Comparison

ARWR vs VLY Comparison

Compare ARWR & VLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • VLY
  • Stock Information
  • Founded
  • ARWR 2003
  • VLY 1927
  • Country
  • ARWR United States
  • VLY United States
  • Employees
  • ARWR N/A
  • VLY N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • VLY Major Banks
  • Sector
  • ARWR Health Care
  • VLY Finance
  • Exchange
  • ARWR Nasdaq
  • VLY Nasdaq
  • Market Cap
  • ARWR 5.9B
  • VLY 5.2B
  • IPO Year
  • ARWR 1993
  • VLY N/A
  • Fundamental
  • Price
  • ARWR $40.96
  • VLY $11.10
  • Analyst Decision
  • ARWR Strong Buy
  • VLY Buy
  • Analyst Count
  • ARWR 8
  • VLY 15
  • Target Price
  • ARWR $47.75
  • VLY $12.80
  • AVG Volume (30 Days)
  • ARWR 1.7M
  • VLY 13.9M
  • Earning Date
  • ARWR 11-25-2025
  • VLY 10-23-2025
  • Dividend Yield
  • ARWR N/A
  • VLY 3.96%
  • EPS Growth
  • ARWR N/A
  • VLY 40.78
  • EPS
  • ARWR N/A
  • VLY 0.88
  • Revenue
  • ARWR $572,976,000.00
  • VLY $1,704,193,000.00
  • Revenue This Year
  • ARWR $21,287.22
  • VLY $33.72
  • Revenue Next Year
  • ARWR N/A
  • VLY $10.10
  • P/E Ratio
  • ARWR N/A
  • VLY $12.62
  • Revenue Growth
  • ARWR 2816.20
  • VLY 8.06
  • 52 Week Low
  • ARWR $9.57
  • VLY $7.48
  • 52 Week High
  • ARWR $43.69
  • VLY $11.35
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 60.87
  • VLY 58.14
  • Support Level
  • ARWR $37.35
  • VLY $10.67
  • Resistance Level
  • ARWR $42.00
  • VLY $11.19
  • Average True Range (ATR)
  • ARWR 2.18
  • VLY 0.35
  • MACD
  • ARWR -0.28
  • VLY 0.03
  • Stochastic Oscillator
  • ARWR 61.35
  • VLY 85.67

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

Share on Social Networks: